The University of Chicago Header Logo

Connection

Seenu Hariprasad to Peptides

Back to Details
This is a "connection" page, showing publications Seenu Hariprasad has written about Peptides.
Seenu Hariprasad
Connection Strength
0.575
Peptides
  1. Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema. Expert Opin Investig Drugs. 2020 Jun; 29(6):547-554.
    View in: PubMed
    Score: 0.575
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.